TuHURA Biosciences, Inc. (HURA) — Stock Score Summary

TuHURA Biosciences, Inc. (HURA) has a MoatMap StockRank of 22/100 based on Quality (28/100), Value (34/100), and Momentum (48/100) factor scores. The current signal is SELL. TuHURA Biosciences is a micro-cap biotech company with no approved products and high development risk. It does not possess the validated manufacturing assets or cash flows of a high-moat CDMO.

TuHURA Biosciences, Inc. is a clinical-stage oncology company developing novel immunotherapies to transform cancer treatment, having recently completed a de-SPAC transaction. The company focuses on leveraging its proprietary technologies to stimulate anti-tumor immune responses. Its innovative approach targets challenging cancers with the potential for improved patient outcomes.

Key Financial Metrics

Price$2.12
Market Cap$150M
P/E (Forward)-3.78
Price/Book6.08
Return on Equity-187.2%
Return on Invested Capital-137.3%
Debt/Equity1.97
Gross Margin0.0%
Operating Margin0.0%
Free Cash Flow$-2M

TuHURA Biosciences, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is TuHURA Biosciences, Inc.’s (HURA) StockRank?
MoatMap’s StockRank for TuHURA Biosciences, Inc. (HURA) is 22/100, with a Sell signal. It is a composite of Quality (28), Value (34), and Momentum (48) factor ranks across MoatMap’s 19,000+ stock universe.
Does TuHURA Biosciences, Inc. have an economic moat?
TuHURA Biosciences, Inc. (HURA) has a Quality factor score of 28/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is TuHURA Biosciences, Inc. a buy, hold, or sell?
MoatMap’s current signal for TuHURA Biosciences, Inc. (HURA) is Sell, based on a StockRank of 22/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is TuHURA Biosciences, Inc. in?
TuHURA Biosciences, Inc. (HURA) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksHURA deep dive reportAI ChampionsHow we score stocksSense-check another stock